There is a strong argument for the use of antifungal prophylaxis in high‐risk patients given
the significant mortality associated with invasive fungal disease, the late identification of …

Whilst some evidence exists to guide IFD prophylaxis using new targeted therapies for
hematological malignancies, there is an overall lack of descriptive, robust studies …

Invasive fungal diseases (IFDs) represent an important cause of treatment failure in adults
with acute leukemia. Because of leukemia's heterogeneity, the risk for IFDs is highly …

Isavuconazole is the first broad spectrum prodrug triazole with efficacy against invasive
fungal diseases including aspergillosis and mucormycosis. Characteristics include linear …

The basis for this is the awareness of general practitioner in the current issues of
epidemiology, clinical picture, diagnosis and treatment of invasive candidiasis in various …

Epidemiology of invasive fungal disease in lymphoproliferative disorders - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Objectives The primary objectives were to investigate the prescribing practices of primary
antifungal prophylaxis (PAP) and incidence of invasive fungal disease (IFD) in adult patients …

Trends in Medical Mycology (TIMM) is the biennial meeting of the Infectious Disease Group
of the European Organisation for Research and Treatment of Cancer (EORTC) and the …

Invasive fungal disease (IFD) represents an important complication in patients with acute
lymphoid leukemia (ALL). The objectives of this study were to determine the prevalence of …

Acute lymphoblastic leukemia (ALL) patients comprise a highly immunocompromised group
due to factors associated either with the treatment or the disease itself. Invasive mold …